A 67-year-old woman presenting with progressive nausea, vomiting, and weight loss was diagnosed with stage IV hormone receptor-positive, HER2-negative metastatic invasive lobular breast carcinoma that initially manifested as a gastric outlet obstruction (GOO), according to a case report published in medical literature. Computed tomography revealed gastric wall thickening and peritoneal abnormalities, while initial mucosal biopsies yielded false-negative results for malignancy due to the tumor infiltrating deeper tissue layers.
Diagnostic Hurdles in Occult Lobular Breast Carcinoma
Invasive lobular carcinoma (ILC) represents roughly 10% to 15% of invasive breast malignancies, according to background data cited in the case. Unlike invasive ductal carcinoma, ILC lacks E-cadherin expression, which disrupts cell adhesion and drives a diffuse infiltrative growth pattern. This biological behavior leads to uncommon metastatic sites, including the gastrointestinal tract, peritoneum, and retroperitoneum, rather than standard locations like the lungs and liver.
In this patient, gastrointestinal involvement closely mimicked a primary gastric malignancy. Clinical symptoms included recurrent vomiting, poor oral intake, and abdominal discomfort. Laboratory findings on admission showed a hemoglobin level of 9.1 g/dL, a white blood cell count of 13,000 cells/µL, and a potassium level of 2.9 mEq/L, as documented in hospital records.
The Role of EUS-Guided Tissue Acquisition
Initial endoscopic biopsies of the pyloric channel showed only erosive chemical gastropathy without dysplasia or H. pylori. Because clinical suspicion remained high given radiographic findings of a narrow, pinhole-sized pyloric opening, clinicians performed endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) four days later. Cytologic examination identified adenocarcinoma, proving that superficial mucosal biopsies frequently miss ILC because the cancer infiltrates the submucosa and muscularis propria.
Diagnostic laparoscopy subsequently confirmed metastatic carcinoma in the omentum, peritoneum, and a small bowel mesenteric nodule. Notably, peritoneal fluid cytology remained negative for malignant cells despite extensive biopsy-proven peritoneal carcinomatosis, demonstrating that negative fluid cytology does not rule out advanced peritoneal disease.
Pro Tip: When evaluating patients with unexplained gastric outlet obstruction and peritoneal abnormalities, clinicians should maintain a broad differential diagnosis that includes metastatic lobular breast carcinoma, even in patients without a known history of breast cancer. Deeper tissue sampling via EUS-FNA is often required when superficial mucosal biopsies are unrevealing.
Immunohistochemistry and Biomarker Profiling
Pathologists utilized advanced immunohistochemical markers to distinguish the metastatic lesion from primary gastrointestinal cancers. Tissue samples stained positive for cytokeratin AE1/AE3, CK7, GATA3, and TRPS1, while testing negative for CK20 and CDX2. Staining also confirmed attenuated E-cadherin expression, which is characteristic of lobular breast cancer.
Breast biomarker analysis of both gastric and omental specimens revealed strong estrogen receptor expression at 91% to 100%, progesterone receptor positivity ranging from 21% to 30% in the gastric specimen and up to 90% in the omental tissue, and HER2 negativity with an immunohistochemical score of 1+. The Ki-67 proliferation index registered between 10% and 15%. To manage the mechanical obstruction, the patient underwent laparoscopically assisted gastrostomy tube placement and jejunostomy feeding.
Did You Know?
GATA3 and TRPS1 are modern immunohistochemical markers that help pathologists accurately identify tumors of mammary origin, separating them from primary gastrointestinal adenocarcinomas when patients present with atypical metastatic patterns.
Frequently Asked Questions
Why did the initial gastric biopsies miss the cancer?
Metastatic invasive lobular carcinoma tends to infiltrate the deeper layers of the gastrointestinal wall—such as the submucosa and muscularis propria—while sparing the superficial mucosa, leading to false-negative results on standard endoscopic biopsies.
What are the primary symptoms of gastric outlet obstruction caused by metastatic breast cancer?
Patients typically present with progressive nausea, recurrent vomiting, early satiety, abdominal discomfort, and significant unintentional weight loss.
Can peritoneal fluid cytology completely rule out peritoneal carcinomatosis?
No. Peritoneal fluid cytology can yield negative results showing only reactive cells even when patients have extensive, biopsy-proven peritoneal carcinomatosis.
What are your thoughts on utilizing advanced immunohistochemistry for occult presentations of metastatic cancer? Share your insights in the comments below, or explore our archive for more clinical case studies.
Worth a look